Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Keeping Track: Kadmon Chooses RTOR For Belumosudil; NDAs For Novel Imaging Agents And Liquid Anticonvulsants
Oct 12 2020
•
By
Bridget Silverman
Kadmon’s product for graft-versus-host disease uses the popular Real-Time Oncology Review pilot program. • Source: Shutterstock
More from Product Reviews
More from Pink Sheet